Latest Period
Q4 2025
Security Snapshot
Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) Institutional Ownership
CUSIP: 45783C200
13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026
Institutions Reporting
28
Shares (Excl. Options)
2,543,805
Price
$11.00
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common stock, par value $ 0.000001 per share
- Symbol
- TIL on Nasdaq
- Shares outstanding
- 6,505,400
- Price per share
- $8.20
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 2,543,805
- Total reported value
- $27,981,700
- % of total 13F portfolios
- 0%
- Share change
- -158,367
- Value change
- -$4,191,273
- Number of holders
- 28
- Price from insider filings
- $8.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- TIL - Instil Bio, Inc. - Common stock, par value $ 0.000001 per share is tracked under CUSIP 45783C200.
- 28 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 28 to 3 between Q4 2025 and Q1 2026.
- Reported value moved from $27,981,700 to $83,089.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 28 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 45783C200?
CUSIP 45783C200 identifies TIL - Instil Bio, Inc. - Common stock, par value $ 0.000001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45783C200:
Significant Owners of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital IX, LLC | 4.5% | $7,169,276 | 292,743 | Vivo Capital IX, LLC | 30 Jun 2025 |
As of 31 Dec 2025, 28 institutional investors reported holding 2,543,805 shares of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL). This represents 39% of the company’s total 6,505,400 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) together control 39% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 9.9% | 645,600 | 0% | 6.3% | $7,101,600 |
| CPMG Inc | 6.3% | 410,922 | 0% | 18% | $4,520,142 |
| Vivo Capital, LLC | 4.5% | 292,743 | 0% | 0.21% | $3,220,173 |
| MILLENNIUM MANAGEMENT LLC | 3.7% | 242,772 | +23% | 0% | $2,670,492 |
| Siren, L.L.C. | 3.1% | 203,933 | 0% | 0.07% | $2,243,263 |
| VANGUARD GROUP INC | 2.9% | 191,060 | +14% | 0% | $2,101,660 |
| MORGAN STANLEY | 1.4% | 88,979 | -14% | 0% | $978,769 |
| RENAISSANCE TECHNOLOGIES LLC | 1% | 67,800 | 0% | $745,800 | |
| DIMENSIONAL FUND ADVISORS LP | 0.94% | 61,025 | -24% | 0% | $670,989 |
| BlackRock, Inc. | 0.79% | 51,213 | -17% | 0% | $563,343 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 0.77% | 50,000 | 0% | 0% | $550,000 |
| CITADEL ADVISORS LLC | 0.73% | 47,335 | 0% | $520,685 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.66% | 42,706 | +0.87% | 0% | $469,950 |
| AlphaQuest LLC | 0.57% | 37,279 | +153% | 0.02% | $410,069 |
| LPL Financial LLC | 0.51% | 33,080 | -1.8% | 0% | $363,875 |
| Quadrature Capital Ltd | 0.3% | 19,198 | 0% | $211,178 | |
| STATE STREET CORP | 0.27% | 17,595 | 0% | 0% | $193,545 |
| Americana Partners, LLC | 0.25% | 16,176 | +52% | 0% | $177,936 |
| XTX Topco Ltd | 0.19% | 12,267 | 0% | $134,937 | |
| BARCLAYS PLC | 0.16% | 10,145 | +65% | 0% | $111,595 |
| ROYAL BANK OF CANADA | 0.02% | 1,368 | +378% | 0% | $15,000 |
| UBS Group AG | 0.01% | 359 | -94% | 0% | $3,949 |
| RHUMBLINE ADVISERS | 0% | 114 | 0% | 0% | $1,254 |
| Farther Finance Advisors, LLC | 0% | 70 | -37% | 0% | $770 |
| EQ WEALTH ADVISORS, LLC | 0% | 40 | 0% | $440 |
Institutional Holders of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 10,134 | $83,089 | +$82,527 | $8.20 | 3 |
| 2025 Q4 | 2,543,805 | $27,981,700 | -$4,191,273 | $11.00 | 28 |
| 2025 Q3 | 2,655,269 | $47,423,593 | -$2,963,439 | $17.86 | 33 |
| 2025 Q2 | 2,751,266 | $57,311,087 | -$11,020,093 | $20.83 | 37 |
| 2025 Q1 | 3,353,462 | $58,216,200 | -$97,479 | $17.36 | 42 |
| 2024 Q4 | 3,339,375 | $63,749,218 | -$66,077,020 | $19.09 | 39 |
| 2024 Q3 | 3,419,403 | $230,187,844 | +$81,138,546 | $67.32 | 48 |
| 2024 Q2 | 2,328,646 | $23,960,769 | -$220,805 | $10.29 | 29 |
| 2024 Q1 | 2,348,572 | $25,363,318 | +$3,416,073 | $10.80 | 30 |
| 2023 Q4 | 2,037,306 | $15,523,621 | +$13,556,922 | $7.62 | 27 |